MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Unstable Angina Pectoris Trial

Phase 3
Completed
Conditions
Angina, Unstable
Heart Diseases
Coronary Disease
Cardiovascular Diseases
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000486

Granulocyte Transfusion Study

Phase 3
Completed
Conditions
Blood Transfusion
Infection
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000581

Inhaled Beclomethasone to Prevent Chronic Lung Disease

Phase 3
Completed
Conditions
Bronchopulmonary Dysplasia
Hyaline Membrane Disease
Lung Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000576

Beta-Blocker Heart Attack Trial (BHAT)

Phase 3
Completed
Conditions
Cardiovascular Diseases
Death, Sudden, Cardiac
Coronary Disease
Heart Diseases
Myocardial Infarction
Ventricular Fibrillation
Myocardial Ischemia
Arrhythmia
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000492

Bypass Angioplasty Revascularization Investigation (BARI)

Phase 3
Completed
Conditions
Angina Pectoris
Coronary Disease
Diabetes Mellitus
Cardiovascular Diseases
Myocardial Ischemia
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-05-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000462

Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause

Phase 3
Completed
Conditions
Hypercholesterolemia
Hypertension
Obesity
Diabetes Mellitus
Heart Diseases
Menopause
Cardiovascular Diseases
Postmenopause
First Posted Date
1999-10-28
Last Posted Date
2016-05-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000532

Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE)

Phase 3
Completed
Conditions
Heart Failure
Heart Diseases
Heart Failure, Congestive
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000619

Magnesium in Coronaries (MAGIC)

Phase 3
Completed
Conditions
Myocardial Infarction
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000610

Action to Control Cardiovascular Risk in Diabetes (ACCORD)

Phase 3
Completed
Conditions
Hypercholesterolemia
Diabetes Mellitus, Type 2
Hypertension
Diabetes Mellitus
Coronary Disease
Atherosclerosis
Cardiovascular Diseases
Interventions
Drug: Anti-hyperglycemic Agents
Drug: Anti-hypertensive Agents
First Posted Date
1999-10-28
Last Posted Date
2016-11-22
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
10251
Registration Number
NCT00000620
Locations
🇺🇸

Columbia University, New York, New York, United States

🇺🇸

Veterans Affairs, Memphis, Tennessee, United States

🇨🇦

McMaster University, Hamilton, Ontario, Canada

and more 4 locations

Enalapril After Anthracycline Cardiotoxicity

Phase 3
Completed
Conditions
Heart Diseases
Myocardial Diseases
Cardiovascular Diseases
Heart Failure
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000547
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy